Video
Benchling helps Xilio Therapeutics see complex lessons in their data
Xilio Therapeutics is committed to transforming cancer treatment by unleashing the full power of highly potent immunotherapies in tumors. As the company grows and scales, however, sharing and accessing valuable data can become a challenge.
In this video, you’ll learn how Xilio Therapeutics sustained their impact by using Benchling to:
Store data in a more uniform and structured way
Simplify naming, linking, and editing of sequences
Extend easier access to data within and across teams
Join over 200,000 scientists using Benchling to power their biotech R&D
